Vascular Closure Market Makes Room For Innovative Solutions

29 Jul 2015

• By Peter Charlish

The $1 billion vascular closure market is primed for growth. It comes on the back of intensive R&D that has spawned a range of alternatives to the traditional manual/compression approach, giving SJM and the sector’s other heavyweights cause to look over their shoulders.

According to the American Heart Association, 1.3 million percutaneous coronary interventions such as angioplasty are carried out in the US each year, mainly via the femoral artery. Although such procedures are generally regarded as relatively safe and complication-free, this has not always been the case.

Percutaneous interventions involve the use of a trocar to puncture the artery and create a conduit through which a device...